Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

3.08
Delayed Data
As of Jun 27
 +0.05 / +1.65%
Today’s Change
1.65
Today|||52-Week Range
5.70
+77.01%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
AssetsCash243.4M239.5M182.5M116.7M
 
 
 
 
 
Short Term Investment Cash10.2M-3.7M18.1M-65.8M
 
 
 
 
 
Cash & Short Term Investments264.4M241.0M194.0M126.6M
 
 
 
 
 
 
ReceivablesReceivables2.9M2.1M1.1M6.3M
 
 
 
 
 
 
InventoriesInventories11.5M24.0M23.2M20.7M
 
 
 
 
 
 
Current AssetsOther Current Assets4.0M6.1M6.2M4.9M
 
 
 
 
 
Current Assets282.7M273.2M224.5M158.5M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross3.8M3.8M3.7M3.7M
 
 
 
 
 
Depreciation-2.4M-2.5M-2.6M-2.7M
 
 
 
 
 
Intangible Assets--78.0M76.1M74.1M
 
 
 
 
Other Assets61.2M81.2M78.9M76.7M
 
 
 
 
 
Total Assets345.4M355.8M304.6M236.4M
 
 
 
 
 
 
LiabilitiesAccounts Payable4.1M12.0M15.2M15.6M
 
 
 
 
 
Accrued Expenses17.4M18.8M12.9M9.9M
 
 
 
 
 
Other Current Liabilities27.3M48.0M42.8M30.1M
 
 
 
 
 
Other Liabilities34.8M65.5M65.4M49.5M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt206.4M200.9M166.2M177.2M
 
 
 
 
 
Other Liabilities33.1M0.000.000.00
 
 
Total Liabilities352.1M279.1M244.2M240.9M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock3.3M3.3M3.3M3.3M
 
 
 
 
 
Common Equity-10.0M73.4M57.0M-7.9M
 
 
 
 
 
Total Shareholder Equity-6.7M76.8M60.4M-4.5M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding14.6M14.6M14.6M15.2M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.